RecruitingNot applicableNCT06198517
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
Studying Complications after hematopoietic stem cell transplantation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Yi Zhang
- Intervention
- Moxibustion(other)
- Enrollment
- 266 enrolled
- Eligibility
- 14-60 years · All sexes
- Timeline
- 2024 – 2026
Study locations (4)
- Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Zhengzhou, Henan, China
- Yi Zhang, Wuhan, Hubei, China
- Hematology Department, The First People's Hospital of Yunnan, Kunming, Yunnan, China
- Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Hangzhou, Zhejiang, China
Collaborators
The First People's Hospital of Yunnan · The First Affiliated Hospital of Zhengzhou University · First Affiliated Hospital of Zhejiang University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06198517 on ClinicalTrials.govOther trials for Complications after hematopoietic stem cell transplantation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06625372Comparison of Intralipid With SMOF Lipid Following HSCTShahid Beheshti University
- RECRUITINGNANCT06241274Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCTUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology
See all trials for Complications after hematopoietic stem cell transplantation →